Nanostructure-enhanced platelet binding and hemostatic structures
First Claim
1. A platelet binding structure, comprising:
- a base structure that comprises carboxymethylcellulose (CMC); and
a plurality of inorganic nanostructures incorporated with the base structure wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 mg/cm2 and about 100 mg/cm2;
wherein the nanostructures are configured to induce platelet binding when the platelet binding structure is contacted with platelets.
5 Assignments
0 Petitions
Accused Products
Abstract
Methods, systems, and apparatuses for nanomaterial-enhanced platelet binding and hemostatic medical devices are provided. Hemostatic materials and structures are provided that induce platelet binding, including platelet binding and the coagulation of blood at a wound/opening caused by trauma, a surgical procedure, ulceration, or other cause. Example embodiments include platelet binding devices, hemostatic bandages, hemostatic plugs, and hemostatic formulations. The hemostatic materials and structures may incorporate nanostructures and/or further hemostatic elements such as polymers, silicon nanofibers, silicon dioxide nanofibers, and/or glass beads into a highly absorbent, gelling scaffold. The hemostatic materials and structures may be resorbable.
-
Citations
29 Claims
-
1. A platelet binding structure, comprising:
-
a base structure that comprises carboxymethylcellulose (CMC); and a plurality of inorganic nanostructures incorporated with the base structure wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 mg/cm2 and about 100 mg/cm2; wherein the nanostructures are configured to induce platelet binding when the platelet binding structure is contacted with platelets. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A method of inducing platelet adhesion, comprising:
contacting a plurality of inorganic nanostructures incorporated within a base structure comprising carboxymethylcellulose (CMC) with a population of platelets, wherein the nanostructures are incorporated in the base structure at a density of between about 0.05 mg/cm2 and about 100 mg/cm2. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16)
-
17. A hemostatic structure, comprising:
-
a base structure that includes a first material capable of creating a gel when contacted with blood; and a plurality of hemostatic inorganic nanoparticles incorporated with the base structure wherein the hemostatic nanoparticles have a density in the range of about 0.05 mg per square centimeter of the base structure and about 2 mg per square centimeter of the base structure; wherein the hemostatic nanoparticles are configured to induce hemostasis when the hemostatic structure is contacted with blood. - View Dependent Claims (18, 19, 20, 21, 22, 23, 24)
-
-
25. A method for forming a hemostatic structure, comprising:
-
providing a base structure that includes a first material capable of creating a gel when contacted with blood; and coating the base structure with a plurality of hemostatic inorganic nanoparticles comprising elongated silicon nanofibers and/or silicon dioxide nanofibers such that the nanoparticles are configured to induce hemostasis when the hemostatic structure is contacted with blood, wherein said coating comprises suspending the inorganic nanofibers in a solvent and coating the base structure with the solvent. - View Dependent Claims (26, 27, 28, 29)
-
Specification